AFGN Funds $1.13M for platforms to resolve VUS in priority genes

The AFGN will fund 6 projects totalling $1.13M that will deliver gene-specific platforms to functionally validate variants of uncertain significance (VUS) in genes of high clinical priority.

View

FOR ACTION: Involve Australia Community Involvement Guidelines Consultation

The Involve Australia project is seeking input from researchers on their Guidelines for Community Involvement in Genomics Research. These guidelines aim to support researchers and the community to create collaborative genomic research projects.

View

Phenomics Australia launches voucher scheme to boost translational research in partnership with TIA

Through the National Collaborative Research Infrastructure Strategy (NCRIS) program, Phenomics Australia and TIA support a network of national research infrastructure to address the medical products challenge in the 2021 National Research Infrastructure (NRI) Roadmap. Collectively, they offer academic researchers and SMEs access to a diverse range of Australian translational medical research capabilities, from the molecular…

View

Funding opportunity: FxGx platforms to assess multiple VUS in priority genes

Registered researchers are invited to complete an expression of interest form to establish platforms to resolve multiple VUS in priority genes identified through Shariant. Applications close on Monday March 27th.

View

Project opportunity: Unmatched genes requiring investigation

Do you have the capacity to functionally analyse patient variants in known disease genes? Browse our list of unmatched genes that are currently eligible for project funding.

View

International Congress of Genetics 2023

Abstract submissions close on 31 January 2023. The AFGN is helping to curate two symposia at the International Congress of Genetics 2023 focusing on functional genomics research. We encourage members to consider submitting an abstract to these symposia.

View

Highlights from 2022

2022 marked the first year that the AFGN was open for submissions. The following article highlights some of our achievements during year 1.

View